NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables.

Author(s): Bai Y, Tolles J, Cheng H, Siddiqui S, Gopinath A, Pectasides E, Camp RL, Rimm DL, Molinaro AM

Publication: Lab Invest, 2011, Vol. 91, Page 1253-61

PubMed ID: 21519325 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of cold ischemia time, surgical procedure type, and the analysis of tissue microarrays versus whole tissue sections on quantitative immunofluorescence of proteins and phospho-proteins usingAutomated Quantitative Analysis (AQUA).

Conclusion of Paper

Statistically insignificant differences were seen between core needle biopsies (CNB) and surgical resections (SR) in the antigenicity of phosphorylated extracellular-signal-regulated kinase (pERK), phosphorylated serine/threonine protein kinase (pAKT), phosphorylated Tyrosine (pTyr), and Ki67 when AQUA scores were obtained from tissue microarrays, while no differences were seen for estrogen receptor (ER) or p53. Upon evaluation of whole tissue sections, immunofluorescence staining of pAKT, pERK, ER, cytokeratin, and phosphorylated ribosomal protein S6 kinase beta-1 (pS6K1) was significantly lower in SR compared to CNB (p<0.05). At the same time, total AKT, ERK, S6K1, Ki67, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were not affected by surgical procedure type, however the authors subsequently determined their sample size was not large enough to detect total protein differences for these epitopes.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of cold ischemia time, surgical procedure type, and the analysis of tissue microarrays versus whole tissue sections on quantitative immunofluorescence of proteins and phospho-proteins using AQUA. The median time between acquisition of core needle biopsy and surgical resection was 27.5 days.

    Summary of Findings:

    When a cohort of 20 paired CNB and SR were examined in a tissue microarray format (AQUA scores from 2 spots for each type of specimen were averaged), no statistically significant differences were seen in the antigenicity of pERK, pAKT, pTyr, ER, p53, or Ki67. However, insignificant decreases in pERK, pAKT, pTyr, and Ki67 were seen for SR compared with CNB. When whole tissue sections were evaluated from a second cohort of 14 matched CNB and SR, pAKT, pERK, ER, cytokeratin, and pS6K1 immunofluorescence was significantly lower in SR (average of 19 20x fields of view) compared to CNB (average of 11 20x fields of view; p<0.05). For ER, the authors report that none of the cases would have changed from an ER-positive status in the CNB to an ER-negative status with the SR. At the same time, total AKT, ERK, S6K1, Ki67, and GAPDH were not affected by surgical procedure type, however the authors subsequently determined their sample size was not large enough to detect total protein epitope differences for AKT, ERK, S6K1, Ki67, and GAPDH.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunohistochemistry
    Protein Tissue microarray
    Small molecule Immunohistochemistry
    Morphology Fluorescent microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Cold ischemia time 0 min
    1-5 h
    Immunohistochemistry Specific Targeted peptide/protein pAKT
    AKT
    pERK
    ERK
    pS6K1
    S6K1
    GAPDH
    Ki67
    ER
    pTyr
    p53
    Cytokeratin
    Biospecimen Aliquots and Components Type of slide Tissue microarray
    Whole tissue section
    Biospecimen Aliquots and Components Aliquot size/volume Two 1.5 mM tissue microarray cores
    An average of 11 20x fields of view
    An average of 19 20x fields of view
    Biospecimen Acquisition Method of tissue acquisition Core needle biopsy
    Surgical resection

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...